Literature DB >> 12511152

Trials and tribulations: current challenges in conducting clinical trials.

Lillian S Kao1, Beth C Aaron, E Patchen Dellinger.   

Abstract

Randomized controlled trials are the gold standard for the evaluation of new therapies and surgical procedures and as such require strict attention to study design and statistical analysis. There are, however, multiple challenges in conducting a well-designed clinical trial. This article describes the difficulties encountered at a single institution participating in a multicenter drug study and reviews the challenges involved in developing a high-quality randomized controlled study.

Mesh:

Substances:

Year:  2003        PMID: 12511152     DOI: 10.1001/archsurg.138.1.59

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  5 in total

1.  Practical tips for surgical research: blinding: who, what, when, why, how?

Authors:  Paul J Karanicolas; Forough Farrokhyar; Mohit Bhandari
Journal:  Can J Surg       Date:  2010-10       Impact factor: 2.089

Review 2.  Knowledge translation and implementation in spinal cord injury: a systematic review.

Authors:  V K Noonan; D L Wolfe; N P Thorogood; S E Park; J T Hsieh; J J Eng
Journal:  Spinal Cord       Date:  2014-05-06       Impact factor: 2.772

3.  A randomized controlled trial of laparoscopic versus open cholecystectomy in patients with cirrhotic portal hypertension.

Authors:  Wu Ji; Ling-Tang Li; Zhi-Ming Wang; Zhu-Fu Quan; Xun-Ru Chen; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

4.  Participation of pharmacists in clinical trial recruitment for low back pain.

Authors:  Christina Abdel Shaheed; Christopher G Maher; Kylie A Williams; Andrew J McLachlan
Journal:  Int J Clin Pharm       Date:  2014-08-08

5.  Worldwide trends in volume and quality of published protocols of randomized controlled trials.

Authors:  Belle V van Rosmalen; Ingo Alldinger; Kasia P Cieslak; Roos Wennink; Mike Clarke; Usama Ahmed Ali; Marc G H Besselink
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.